Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma Meeting Abstract

  

Authors:	Grommes, C.; Stone, J.; Nolan, C.; Tsyvkin, E.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
Abstract Title:	Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma
Meeting Title:	53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	35
Issue:	15 Suppl.
Meeting Dates:	2017 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2017-05-20
Start Page:	400s
Language:	English
ACCESSION:	WOS:000411931709020
DOI:	10.1200/JCO.2017.35.15_suppl.7533
PROVIDER:	wos
Notes:	Meeting Abstract: 7533 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/147146